Articolul precedent |
Articolul urmator |
520 1 |
Ultima descărcare din IBN: 2022-12-20 12:30 |
SM ISO690:2012 FURMANOVA, N, VERIN, I., GELMBOLDT, Vladimir, GANIN, Eduard, WANG, Wen-Jwu, SIMONOV, Yurii A., FONARI, Marina. Supramolecular isomerism in the system [Crown-Ether.H3O]MF6 (M= Ta, Nb). In: Physical Methods in Coordination and Supramolecular Chemistry, 27 septembrie - 1 octombrie 2006, Chişinău. Chisinau, Republic of Moldova: 2006, XVII, p. 126. ISBN 978-9975-62-066-6. |
EXPORT metadate: Google Scholar Crossref CERIF DataCite Dublin Core |
Physical Methods in Coordination and Supramolecular Chemistry XVII, 2006 |
|
Conferința "The XV-th International Conference Physical Methods in Coordination and Supramolecular Chemistry : The XVII-th Reading in memory of Acad. A.Ablov" Chişinău, Moldova, 27 septembrie - 1 octombrie 2006 | |
|
|
Pag. 126-126 | |
Descarcă PDF | |
Rezumat | |
Supramolecular isomerism (SI) in coordination polymers has received increasing interest n recent years for fundamental and applied reasons [1]. he occurrence of SI implies superstructural diversity for a given building block. We report the crystal structures a given building block. We report the crystal structures or the systems, [CE(crown-ether).H O]MF (M=Ta, Nb), f 3 6 where CE=benzo-18C6, cis-syn-cis-DCH18C6, which afford novel examples of SI. It was stated the influence of the synthetic route on the crystallography of the final product: the interaction of Ta2O5 with HF in the presence of corresponding CE results in the monoclinic modifications regardless of CE used (P2 /n both), while interaction of TaF with CE in the medium of HF results in an orthorhombic isomer for [B18C6.H3O]TaF6 (Pbca) and triclinic one (P-1) for [DCH18C6.H3O]TaF6. For these latter complexes the isostructural Nb counterparts were obtained. For [B18C6. H3O]TaF6 the distinction between the isomers is dictated by the packing conditions of the quite similar building blocks (fig.), while in [DCH18C6.H3O]TaF6 the macrocyclic molecule exhibits strictly different conformations in monoclinic and triclinic modifications [2,3]. schemeMonoclinic and orthorhombic isomers for [B18C6.H3O]TaF6 |
|
|
Cerif XML Export
<?xml version='1.0' encoding='utf-8'?> <CERIF xmlns='urn:xmlns:org:eurocris:cerif-1.5-1' xsi:schemaLocation='urn:xmlns:org:eurocris:cerif-1.5-1 http://www.eurocris.org/Uploads/Web%20pages/CERIF-1.5/CERIF_1.5_1.xsd' xmlns:xsi='http://www.w3.org/2001/XMLSchema-instance' release='1.5' date='2012-10-07' sourceDatabase='Output Profile'> <cfResPubl> <cfResPublId>ibn-ResPubl-105589</cfResPublId> <cfResPublDate>2006</cfResPublDate> <cfVol>XVII</cfVol> <cfStartPage>126</cfStartPage> <cfISBN>978-9975-62-066-6</cfISBN> <cfURI>https://ibn.idsi.md/ro/vizualizare_articol/105589</cfURI> <cfTitle cfLangCode='EN' cfTrans='o'>Supramolecular isomerism in the system [Crown-Ether.H3O]MF6 (M= Ta, Nb)</cfTitle> <cfAbstr cfLangCode='EN' cfTrans='o'><p>Supramolecular isomerism (SI) in coordination polymers has received increasing interest n recent years for fundamental and applied reasons [1]. he occurrence of SI implies superstructural diversity for a given building block. We report the crystal structures a given building block. We report the crystal structures or the systems, [CE(crown-ether).H O]MF (M=Ta, Nb), f 3 6 where CE=benzo-18C6, cis-syn-cis-DCH18C6, which afford novel examples of SI. It was stated the influence of the synthetic route on the crystallography of the final product: the interaction of Ta2O5 with HF in the presence of corresponding CE results in the monoclinic modifications regardless of CE used (P2 /n both), while interaction of TaF with CE in the medium of HF results in an orthorhombic isomer for [B18C6.H3O]TaF6 (Pbca) and triclinic one (P-1) for [DCH18C6.H3O]TaF6. For these latter complexes the isostructural Nb counterparts were obtained. For [B18C6. H3O]TaF6 the distinction between the isomers is dictated by the packing conditions of the quite similar building blocks (fig.), while in [DCH18C6.H3O]TaF6 the macrocyclic molecule exhibits strictly different conformations in monoclinic and triclinic modifications [2,3]. </p><p>scheme</p><p>Monoclinic and orthorhombic isomers for [B18C6.H3O]TaF6</p></cfAbstr> <cfResPubl_Class> <cfClassId>eda2d9e9-34c5-11e1-b86c-0800200c9a66</cfClassId> <cfClassSchemeId>759af938-34ae-11e1-b86c-0800200c9a66</cfClassSchemeId> <cfStartDate>2006T24:00:00</cfStartDate> </cfResPubl_Class> <cfResPubl_Class> <cfClassId>e601872f-4b7e-4d88-929f-7df027b226c9</cfClassId> <cfClassSchemeId>40e90e2f-446d-460a-98e5-5dce57550c48</cfClassSchemeId> <cfStartDate>2006T24:00:00</cfStartDate> </cfResPubl_Class> <cfPers_ResPubl> <cfPersId>ibn-person-15491</cfPersId> <cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId> <cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId> <cfStartDate>2006T24:00:00</cfStartDate> </cfPers_ResPubl> <cfPers_ResPubl> <cfPersId>ibn-person-79643</cfPersId> <cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId> <cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId> <cfStartDate>2006T24:00:00</cfStartDate> </cfPers_ResPubl> <cfPers_ResPubl> <cfPersId>ibn-person-56516</cfPersId> <cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId> <cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId> <cfStartDate>2006T24:00:00</cfStartDate> </cfPers_ResPubl> <cfPers_ResPubl> <cfPersId>ibn-person-77037</cfPersId> <cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId> <cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId> <cfStartDate>2006T24:00:00</cfStartDate> </cfPers_ResPubl> <cfPers_ResPubl> <cfPersId>ibn-person-79644</cfPersId> <cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId> <cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId> <cfStartDate>2006T24:00:00</cfStartDate> </cfPers_ResPubl> <cfPers_ResPubl> <cfPersId>ibn-person-1070</cfPersId> <cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId> <cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId> <cfStartDate>2006T24:00:00</cfStartDate> </cfPers_ResPubl> <cfPers_ResPubl> <cfPersId>ibn-person-1018</cfPersId> <cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId> <cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId> <cfStartDate>2006T24:00:00</cfStartDate> </cfPers_ResPubl> </cfResPubl> <cfPers> <cfPersId>ibn-Pers-15491</cfPersId> <cfPersName_Pers> <cfPersNameId>ibn-PersName-15491-3</cfPersNameId> <cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId> <cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId> <cfStartDate>2006T24:00:00</cfStartDate> <cfFamilyNames>Фурманова</cfFamilyNames> <cfFirstNames>Н</cfFirstNames> </cfPersName_Pers> </cfPers> <cfPers> <cfPersId>ibn-Pers-79643</cfPersId> <cfPersName_Pers> <cfPersNameId>ibn-PersName-79643-3</cfPersNameId> <cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId> <cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId> <cfStartDate>2006T24:00:00</cfStartDate> <cfFamilyNames>Verin</cfFamilyNames> <cfFirstNames>I.</cfFirstNames> </cfPersName_Pers> </cfPers> <cfPers> <cfPersId>ibn-Pers-56516</cfPersId> <cfPersName_Pers> <cfPersNameId>ibn-PersName-56516-3</cfPersNameId> <cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId> <cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId> <cfStartDate>2006T24:00:00</cfStartDate> <cfFamilyNames>Gelmboldt</cfFamilyNames> <cfFirstNames>Vladimir</cfFirstNames> <cfFamilyNames>Гельмболдт</cfFamilyNames> <cfFirstNames>Владимир</cfFirstNames> </cfPersName_Pers> </cfPers> <cfPers> <cfPersId>ibn-Pers-77037</cfPersId> <cfPersName_Pers> <cfPersNameId>ibn-PersName-77037-3</cfPersNameId> <cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId> <cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId> <cfStartDate>2006T24:00:00</cfStartDate> <cfFamilyNames>Ганин</cfFamilyNames> <cfFirstNames>Эдуард</cfFirstNames> </cfPersName_Pers> </cfPers> <cfPers> <cfPersId>ibn-Pers-79644</cfPersId> <cfPersName_Pers> <cfPersNameId>ibn-PersName-79644-3</cfPersNameId> <cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId> <cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId> <cfStartDate>2006T24:00:00</cfStartDate> <cfFamilyNames>Wang</cfFamilyNames> <cfFirstNames>Wen-Jwu</cfFirstNames> </cfPersName_Pers> </cfPers> <cfPers> <cfPersId>ibn-Pers-1070</cfPersId> <cfPersName_Pers> <cfPersNameId>ibn-PersName-1070-3</cfPersNameId> <cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId> <cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId> <cfStartDate>2006T24:00:00</cfStartDate> <cfFamilyNames>Simonov</cfFamilyNames> <cfFirstNames>Yurii A.</cfFirstNames> <cfFamilyNames>Симонов</cfFamilyNames> <cfFirstNames>Юрий</cfFirstNames> </cfPersName_Pers> </cfPers> <cfPers> <cfPersId>ibn-Pers-1018</cfPersId> <cfPersName_Pers> <cfPersNameId>ibn-PersName-1018-3</cfPersNameId> <cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId> <cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId> <cfStartDate>2006T24:00:00</cfStartDate> <cfFamilyNames>Fonari</cfFamilyNames> <cfFirstNames>Marina</cfFirstNames> </cfPersName_Pers> </cfPers> </CERIF>